As a well-known targeted drug for the treatment of cancer, sorafenib tosylate tablets (the product name is NEXAVAR) encountered a patent invalidation dispute. Recently, the National Intellectual Property Administration, PRC made the review decision No. 46292, the patent for sorafenib tosylate prepar
On November 9, the Supreme People's Court held a press conference and issued the "Opinions of the Supreme People's Court on Supporting and Guaranteeing Shenzhen's Construction of a Pilot Demonstration Zone for Socialism with Chinese Characteristics." Gong Jiali, president of th
From November 11th to 13th, the 12th China International Patent Technology and Product Fair, co-sponsored by the National Intellectual Property Administration, PRC and the People's Government of Liaoning Province, will be held in Dalian, Liaoning Province. The biggest highlights of this Fair are
On October 17, the 22nd Session of the Standing Committee of the 13th National People's Congress(NPC) approved the newly amended patent law, which will be effective on June 1 next year. The amendment, which had been drawing keen attention from foreign and Chinese innovators and the public at lar
A German appeals court on Monday lifted the enforcement of an injunction won by Nokia Oyj in a patent dispute with Lenovo Group Ltd to block the world’s largest PC maker from selling its products in Europe’s largest economy.Nokia last month enforced the order issued by a lower court in Munich, which
